In agreement with the pharmacological data, genetic loss of function models of FGF21 aggravates obesity-induced and impairs the thermogenic response, possibly via increased hypothalamic inflammation [75]. Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.